Keywords

Details

Category:

Articles

Type:

artykuł w czasopiśmie wyróżnionym w JCR

Published in:

NEW JOURNAL OF CHEMISTRY no. 41, edition 6, pages 2479 - 2489,
ISSN: 1144-0546

Language:

English

Publication year:

2017

Bibliographic description:

Anna Z., Ewelina N., Makowiec S.: A new approach to the stereoselective synthesis of trans-3-carbamoyl-b-lactam moieties†// NEW JOURNAL OF CHEMISTRY. -Vol. 41, iss. 6 (2017), s.2479-2489

DOI:

Digital Object Identifier (open in new tab) 10.1039/c7nj00445a

Bibliography: test

1. -(4-Fluorophenyl)-4-oxo-N-phenyl-1-(1-phenylethyl)azetidine-3- carboxamide (7ada) and (8ada) Purification by flash chromatography (EtOAc : Hex 1 : 3, SiO 2 ) gave one fraction, a mixture of two diastereoisomers (271 mg, 0.70 mmol, 70%, ratio 75 : 25, yellow oil). Overall de = 50%. open in new tab
2. H NMR (500 MHz, CDCl 3 ) d: 8.37 (s, 0.75 H, NH), 8.32 (s, 0.25 open in new tab
3. H, NH), 7.55 (d, 0.25 H, J = 8.0 Hz, ArH), 7.47 (d, 1.50 H, J = 8.0 open in new tab
4. Hz, ArH), 7.33-7.25 (m, 6.25 H, ArH), 7.23-7.21 (m, 1.75 H, ArH), 7.17-7.07 (m, 2.25 H, ArH), 7.04-6.96 (m, 2 H, ArH), 4.90 (q, 0.75 H, J = 7.0 Hz, CHCH 3 ), 4.82 (d, 1 H, J = 2.5 Hz, H-4), 4.44 (q, 0.25 H, J = 7.0 Hz, CHCH 3 ), 3.92 (d, 0.75 H, J = 2.5 Hz, H-3), 3.89 (d, 0.25 H, J = 2.5 Hz, H-3), 1.79 (d, 0.75 H, J = 7.0 Hz, CH 3 ), 1.43 (d, 2.25 H, J = 7.0 Hz, CH 3 ) ppm. 13 C NMR (125 MHz, CDCl 3 ) d: 165.4 (maj), 164.4 (d, 1 J CF = 235 Hz), 164.0 (min), 163.3 (maj), 163.0 (d, 1 J CF = 246 Hz), 162.1 (maj), 140.2 (min), 139.3 (maj), 137.6 (min), 137.5 (maj), 133.6 (d, 4 J CF = 2 Hz), 129.2 (min), 129.1 (maj), 129.0, 128.9 (d, 3 J CF = 7 Hz) (maj), 128.8 (d, 3 J CF = 7 Hz) (min), 128.3 (maj), 128.1 (min), 127.4 (maj), 127.0 (min), 124.9 (min), 124.0 (maj), 120.2 (min), 120.1 (maj), 116.2 (d, 2 J CF = 21 Hz) (min), 116.1 (d, 2 J CF = 21 Hz) (maj), 63.3, 57.3 (maj), 56.7 (min), 54.9 (min), 53.8 (maj), 19.9 (min), 19.5 (maj) ppm. HRMS (ESI+): m/z calcd for C 24 H 21 FN 2 O 2 Na [M + Na] + 411.1485, found. 411.1470. open in new tab
5. N-(4-Methoxyphenyl)-2-oxo-4-phenyl-1-(1- phenylethyl)azetidine-3-carboxamide (7daa) and (8daa) Purification by flash chromatography (EtOAc : Hex 1 : 8, SiO 2 ) gave one fraction, a mixture of two diastereoisomers (280 mg, 0.70 mmol, 70%, ratio 75 : 25, yellow oil). Overall de = 50%. open in new tab
6. H NMR (500 MHz, CDCl 3 ) d: 8.26 (s, 0.75 H, NH), 8.20 (s, 0.25 open in new tab
7. H, NH), 7.46-7.40 (m, 0.75 H, ArH), 7.40-7.36 (m, 1.25 H, ArH), 7.34-7.28 (m, 6.25 H, ArH), 7.26-7.21 (m, 3 H, ArH), 7.19-7.16 (m, 0.75 H, ArH), 6.85-6.83 (m, 0.75 H, ArH), 6.80-6.77 (m, 1.25 open in new tab
8. H, ArH), 4.92 (q, 0.75 H, J = 7.0 Hz, CHCH 3 ), 4.83 (d, 0.75 H, J = 2.0 Hz, H-4), 4.80 (d, 0.25 H, J = 2.0 Hz, H-4), 4.40 (q, 0.25 H, J = 7.0 Hz, CHCH 3 ), 3.92 (d, 0.75 H, J = 2.0 Hz, H-3), 3.89 (d, 0.25 open in new tab
9. H, J = 2.0 Hz, H-3), 3.78 (s, 0.75 H, OCH 3 ), 3.77 (s, 2.25 H, OCH 3 ), 1.79 (d, 0.75 H, J = 7.5 Hz, CH 3 ), 1.41 (d, 2.25 H, J = 7.5 Hz, CH 3 ) ppm. 13 C NMR (125 MHz, CDCl 3 ) d: 165.6 (maj), 165.5 (min), 163.4 (min), 163.2 (maj), 156.7 (min), 156.6 (maj), 140.6, 139.5, 138.0, 136.9, 130.8, 129.2, 129.1, 129.0, 128.9, 128.5, 128.2, 128.0, 127.4, 127.2, 127.1, 127.0, 121.9, 121.8, 114.3 (min), 114.2 (maj), 63.2 (maj), 63.2 (min), 57.9 (maj), 57.5 (min), 55.6 (maj), 55.1 (min), 53.7, 20.2 (min), 19.5 (maj) ppm. HRMS (ESI+): m/z calcd for C 25 H 24 N 2 O 3 Na [M + Na] + 423.1685, found. 423.1671. 2-(tert-Butyl)-4-oxo-N-phenyl-1-(1-phenylethyl)azetidine-3- carboxamide (7aea) and (8aea) Purification by flash chromatography (EtOAc : Hex 1 : 5, SiO 2 ) gave one fraction, a mixture of two diastereoisomers (175 mg, 0.50 mmol, 50%, ratio 74 : 26, yellow oil). Overall de = 48%. open in new tab
10. H NMR (500 MHz, CDCl 3 ) d: 8.57 (s, 0.74 H, NH), 8.38 (s, 0.26 open in new tab
11. H, NH), 7.55-7.50 (m, 1.74 H, ArH), 7.41-7.40 (m, 1.26 H, ArH), 7.37-7.31 (m, 2.26 H, ArH), 7.30-7.26 (m, 3.74 H, ArH), 7.12-7.07 (m, 1 H, ArH), 4.59 (q, 0.26 H, J = 7.5 Hz, CHCH 3 ), 4.50 (q, 0.74 H, J = 7.5 Hz, CHCH 3 ), 3.87 (d, 0.74 H, J = 2.5 Hz, H-3), 3.72 (d, 0.74 H, J = 2.5 Hz, H-4), 3.71 (d, 0.26 H, J = 2.5 Hz, H-3), 3.67 (d, 0.26 H, J = 2.5 Hz, H-4), 1.85 (d, 0.78 H, J = 7.5 Hz, CH 3 ), 1.75 (d, 2.22 H, J = 7.5 Hz, CH 3 ), 0.96 (s, 2.36 H, t Bu), 0.88 (s, 6.63 H, t Bu) ppm. 13 C NMR (125 MHz, CDCl 3 ) d: 166.6 (min), 165.5 (maj), 164.2 (maj), 164.1 (min), 141.5 (maj), 141.2 (min), 137.8 (maj), 137.7 (min), 129.2, 129.1, 128.9, 128.0, 127.7, 127.2, 126.8, 124.7 (min), 124.6 (maj), 120.1 (min), 120.0 (maj), 66.6 (maj), 64.3 (min), 57.4 (maj), 56.7 (min), 55.1 (min), 55.0 (maj), 32.5, 26.5, 26.1, 21.4 (maj), 20.5 (min) ppm. HRMS (ESI+): m/z calcd for C 22 H 26 N 2 O 2 Na [M + Na] + 373.1892, found. 373.1902. 2-(tert-Butyl)-N-(4-methoxyphenyl)-4-oxo-1-(1- phenylethyl)azetidine-3-carboxamide (7dea) and (8dea) Purification by flash chromatography (EtOAc : Hex 1 : 4-1 : 2, SiO 2 ) gave one fraction, a mixture of two diastereoisomers (175 mg, 0.46 mmol, 46%, ratio 70 : 30, yellow oil). Overall de = 40%. open in new tab
12. H NMR (500 MHz, CDCl 3 ) d: 8.59 (s, 0.7 H, NH), 8.33 (s, 0.3 H, NH), 7.45-7.40 (m, 3.3 H, ArH), 7.37-7.33 (m, 2 H, ArH), 7.30-7.25 (m, 1.7 H, ArH), 6.84-6.78 (m, 2 H, ArH), 4.60 (q, 0.3 H, J = 7.0 Hz, CHCH 3 ), 4.50 (q, 0.7 H, J = 7.0 Hz, CHCH 3 ), 3.87 (d, 0.7 H, J = 2.5 Hz, H-3), 3.78 (s, 0.9 H, OCH 3 ), 3.77 (s, 2.1 H, OCH 3 ), 3.72 (d, 0.7 H, J = 2.5 Hz, H-4), 3.70 (d, 0.3 H, J = 2.5 Hz, H-3), 3.66 (d, 0.3 H, J = 2.5 Hz, H-4), 1.85 (d, 0.9 H, J = 7.5 Hz, CH 3 ), 1.75 (d, 2.1 H, J = 7.5 Hz, CH 3 ), 0.95 (s, 2.66 H, t Bu), 0.87 (s, 6.34 H, t Bu) ppm. open in new tab
13. C NMR (125 MHz, CDCl 3 ) d: 166.8 (min), 166.6 (maj), 163.9, 156.7 (min), 156.5 (maj), 141.6 (maj), 141.2 (min), 131.0 (maj), 130.9 (min), 129.1 (min), 128.9 (maj), 127.9 (min), 127.7 (maj), 127.2 (maj), 126.8 (min), 121.7 (min), 121.6 (maj), 114.3 (min), 114.2 (maj), 66.6 (maj), 64.4 (min), 57.3 (maj), 56.6 (min), 55.7 (min), 55.6 (maj), 55.0 (min), 54.9 (maj), 32.5, 26.5 (min), 26.1 (maj), 21.4 (maj), 20.5 (min) ppm. HRMS (ESI+): m/z calcd for C 23 H 28 N 2 O 3 Na [M + Na] + 403.1998, found. 403.2005. 2-(tert-Butyl)-N-(3-chlorophenyl)-4-oxo-1-(1- phenylethyl)azetidine-3-carboxamide (7cea) and (8cea) Purification by flash chromatography (EtOAc : Hex 1 : 5, SiO 2 ) gave one fraction, a mixture of two diastereoisomers (161 mg, 0.42 mmol, 42%, ratio 71 : 29, yellow oil). Overall de = 42%. open in new tab
14. H NMR (500 MHz, CDCl 3 ) d: 9.02 (s, 0.71 H, NH), 8.66 (s, 0.29 open in new tab
15. H, NH), 7.71 (s, 1H, ArH), 7.42-7.40 (m, 1.29 H, ArH), 7.36-7.33 (m, 2 H, ArH), 7.30-7.25 (m, 2 H, ArH), 7.23-7.17 (m, 1 H, ArH), 7.15-7.11 (m, 0.71 H, ArH), 7.06-7.00 (m, 1 H, ArH), 4.60 (q, 0.29 H, J = 7.5 Hz, CHCH 3 ), 4.50 (q, 0.71 H, J = 7.5 Hz, CHCH 3 ), 3.93-3.91 (m, 0.71 H, H-3), 3.81-3.78 (m, 0.71 H, H-3), 3.76-3.74 (m, 0.29 H, H-4), 3.71-3.69 (m, 0.29 H, H-4), 1.85 (d, 0.87 H, J = 7.0 Hz, CH 3 ), 1.77 (d, 2.13 H, J = 7.0 Hz, CH 3 ), 0.95 (s, 2.59 H, t Bu), 0.87 (s, 6.43 H, t Bu) ppm. 13 C NMR (125 MHz, CDCl 3 ) d: 166.5, 164.3, 141.4 (maj), 141.1 (min), 138.9 (maj), 138.8 (min), 134.8 (min), 134.7 (maj), 130.1 (min), 130.0 (maj), 129.1 (min), 128.9 (maj), 128.0 (min), 127.8 (maj), 127.2 (maj), 126.8 (min), 124.6 (min), 124.5 (maj), 120.1 (min), 119.9 (maj), 117.9 (min), 117.7 (maj), 66.4 (maj), 64.2 (min), 57.5 (maj), 56.7 (min), 55.2 (maj), 55.1 (min), 32.5, 26.5 (min), 26.1 (maj), 21.4 (maj), 20.5 (min) ppm. HRMS (ESI+): m/z calcd for C 22 H 25 ClN 2 O 2 Na [M + Na] + 407.1502, found. 407.1509. open in new tab
16. -(tert-Butyl)-1-(1-(naphthalen-2-yl)ethyl)-4-oxo-N- phenylazetidine-3-carboxamide (7aeb) and (8aeb) Purification by flash chromatography (EtOAc : Hex 1 : 4, SiO 2 ) gave one fraction, a mixture of two diastereoisomers (208 mg, 0.52 mmol, 52%, ratio 55 : 45, yellow oil). Overall de = 10%. open in new tab
17. H NMR (500 MHz, CDCl 3 ) d: 8.57 (s, 0.55 H, NH), 8.45 (s, 0.45 open in new tab
18. H, NH), 7.86-7.78 (m, 3.90 H, ArH), 7.72-7.66 (m, 0.55 H, ArH), 7.61-7.54 (m, 2.55 H, ArH), 7.51-7.45 (m, 2.55 H, ArH), 7.32- 7.26 (m, 2.45 H, ArH), 7.13-7.04 (m, 1 H, ArH), 4.80 (q, 0.45 H, J = 7.5 Hz, CHCH 3 ), 4.66 (q, 0.55 H, J = 7.5 Hz, CHCH 3 ), 3.91 (d, 0.55 H, J = 2.5 Hz, H-3), 3.78-3.75 (m, 1 H, H-3 H-4), 3.73 (d, 0.45 H, J = 2.5 Hz, H-4), 1.94 (d, 1.35 H, J = 7.5 Hz, CH 3 ), 1.84 (d, 1.65 H, J = 7.5 Hz, CH 3 ), 0.96 (s, 4.03 H, t Bu), 0.88 (s, 4.96 H, t open in new tab
19. Bu) ppm. 13 C NMR (125 MHz, CDCl 3 ) d: 166.8 (min), 166.6 (maj), 164.2 (maj), 164.1 (min), 139.1 (maj), 138.6 (min), 137.8 (maj), 137.7 (min), 133.5 (maj), 133.4 (min), 133.0 (min), 132.9 (maj), 129.4, 129.3, 129.2, 129.0, 128.2, 127.9, 126.6 (min), 126.5 (maj), 126.4 (maj), 126.3 (min), 125.7, 125.6 (maj), 125.5 (min), 124.9 (min), 124.7 (maj), 120.1 (min), 120.0 (maj), 66.9 (maj), 64.5 (min), 57.6 (maj), 56.5 (min), 55.2 (min), 55.0 (maj), 32.6, 26.5 (min), 26.2 (maj), 21.5 (maj), 20.2 (min) ppm. HRMS (ESI+): m/z calcd for C 26 H 28 N 2 O 2 Na [M + Na] + 423.2048, found. 423.2032. 2-(tert-Butyl)-4-oxo-1-(1-phenylethyl)-N-(m-tolyl)azetidine-3- carboxamide (7eea) and (8eea) Purification by flash chromatography (EtOAc : Hex 1 : 5, SiO 2 ) gave one fraction, a mixture of two diastereoisomers (138 mg, 0.38 mmol, 38%, ratio 67 : 33, yellow oil). Overall de = 34%. open in new tab
20. H NMR (400 MHz, CDCl 3 ) d: 8.39 (s, 0.67 H, NH), 8.32 (s, 0.33
21. H, NH), 7.44-7.29 (m, 7 H, ArH), 7.24-7.19 (m, 1 H, ArH), 6.97- 6.93 (m, 1 H, ArH), 4.60 (q, 0.33 H, J = 7.2 Hz, CHCH 3 ), 4.66 (q, 0.67 H, J = 7.2 Hz, CHCH 3 ), 3.84 (d, 0.67 H, J = 2.8 Hz, H-3), 3.71-3.69 (m, 1 H, H-3 H-4), 3.66 (d, 0.33 H, J = 2.8 Hz, H-4), 2.36 (s, 0.99 H, ArCH 3 ), 2.35 (s, 2.01 H, ArCH 3 ) 1.87 (d, 0.99 H, J = 7.2 Hz, CH 3 ), 1.76 (d, 2.01 H, J = 7.2 Hz, CH 3 ), 0.98 (s, 3.00 H, t Bu), 0.90 (s, 6.05 H, t Bu) ppm. 13 C NMR (100 MHz, CDCl 3 ) d: 166.4 (min), 166.2 (maj), 164.0 (maj), 163.9 (min), 141.3 (maj), 141.0 (min), 139.0 (min), 138.9 (maj), 137.5 (maj), 137.4 (min), 129.0 (min), 128.9 (maj), 128.8 (min), 128.7 (maj), 127.5 (min), 127.0 (maj), 126.5 (maj), 126.2 (min), 125.3 (min), 125.2 (maj), 120.5 (min), 120.4 (maj), 116.9 (min), 116.8 (maj), 66.6 (maj), 64.2 (min), 57.0 (maj), 56.5 (min), 54.7 (min), 54.6 (maj), 32.3, 26.3 (min), 25.9 (maj), 21.5, 21.2 (maj), 20.3 (min) ppm. HRMS (ESI+): m/z calcd for C 23 H 28 N 2 O 2 Na [M + Na] + 387.2048, found. 387.2039. 2-(tert-Butyl)-4-oxo-1-(1-phenylethyl)-N-(o-tolyl)azetidine-3- carboxamide (7fea) and (8fea) Purification by flash chromatography (EtOAc : Hex 1 : 5, SiO 2 ) gave one fraction, a mixture of two diastereoisomers (160 mg, 0.44 mmol, 44%, ratio 65 : 35, yellow oil). Overall de = 30%. open in new tab
22. H NMR (400 MHz, CDCl 3 ) d: 8.33 (s, 1 H, NH), 8.03 (d, 0.65 H, J = 8.0 Hz, ArH), 7.96 (d, 0.35 H, J = 8.0 Hz, ArH), 7.44-7.27 (m, 5 H, ArH), 7.25-7.20 (m, 2 H, ArH), 7.10-7.07 (m, 1 H, ArH), 4.58 (q, 0.35 H, J = 7.2 Hz, CHCH 3 ), 4.52 (q, 0.65 H, J = 7.2 Hz, CHCH 3 ), 3.83 (d, 0.65 H, J = 2.4 Hz, H-3), 3.75 (d, 0.35 H, J = 2.4 Hz, H-3), 3.73 (d, 0.65 H, J = 2.4 Hz, H-4), 3.65 (d, 0.35 H, J = 2.4 Hz, H-4), 2.36 (s, 1.95 H, ArCH 3 ), 2.34 (s, 1.05 open in new tab
23. H, ArCH 3 ), 1.89 (d, 1.05 H, J = 7.2 Hz, CH 3 ), 1.77 (d, 1.95 H, J = 7.2 Hz, CH 3 ), 1.01 (s, 3.15 H, t Bu), 0.92 (s, 5.85 H, t Bu) ppm. open in new tab
24. C NMR (100 MHz, CDCl 3 ) d: 166.7 (min), 166.5 (maj), 164.0 (maj), 163.9 (min), 141.4 (maj), 141.1 (min), 135.6 (maj), 135.5 (min), 130.5 (maj), 130.4 (min), 128.9 (min), 128.7 (maj), 128.4 (min), 128.2 (maj), 127.8 (min), 127.5 (maj), 126.9 (maj), 126.7 (min), 126.6 (min), 126.5 (maj), 124.9 (min), 124.8 (maj), 122.0 (min), 121.7 (maj), 66.8 (maj), 64.3 (min), 57.1 (maj), 56.6 (min), 54.6 (min), 54.4 (maj), 32.3, 26.3 (min), 25.9 (maj), 21.1 (maj), 20.3 (min), 17.7 (maj), 14.2 (min) ppm. HRMS (ESI+): m/z calcd for C 23 H 28 N 2 O 2 Na [M + Na] + 387.2048, found. 387.2041. 2-(tert-Butyl)-4-oxo-1-(1-phenylethyl)-N-( p-tolyl)azetidine-3- carboxamide (7gea) and (8gea) Purification by flash chromatography (EtOAc : Hex 1 : 5, SiO 2 ) gave one fraction, a mixture of two diastereoisomers (127 mg, 0.35 mmol, 35%, ratio 68 : 32, yellow oil). Overall de = 36%. open in new tab
25. H NMR (400 MHz, CDCl 3 ) d: 8.38 (s, 0.68 H, NH), 8.30 (s, 0.32 H, NH), 7.47-7.34 (m, 6 H, ArH), 7.32-7.29 (m, 1 H, ArH), 7.16-7.11 (m, 2 H, ArH), 4.60 (q, 0.32 H, J = 7.2 Hz, CHCH 3 ), 4.52 (q, 0.68 H, J = 7.2 Hz, CHCH 3 ), 3.85 (d, 0.68 H, J = 2.8 Hz, H-3), 3.71-3.69 (m, 1 H, H-3 H-4), 3.66 (d, 0.32 H, J = 2.8 Hz, H-4), 2.35-2.32 (m, 3 H, ArCH 3 ), 1.87 (d, 0.96 H, J = 7.2 Hz, CH 3 ), 1.76 (d, 2.04 H, J = 7.2 Hz, CH 3 ), 0.98 (s, 2.84 H, t Bu), 0.90 (s, 6.15 H, t Bu) ppm. 13 C NMR (100 MHz, CDCl 3 ) d: 166.5 (min), 166.3 (maj), 163.9 (maj), 163.8 (min), 141.3 (maj), 141.0 (min), 135.0 (maj), 134.9 (min), 134.1 (min), 134.0 (maj), 129.5 (min), 129.4 (maj), 128.9 (min), 128.7 (maj), 127.7 (min), 127.5 (maj), 127.0 (maj), 126.5 (min), 119.9 (min), 119.8 (maj), 66.6 (maj), 64.2 (min), 57.0 (maj), 56.5 (min), 54.7 (min), 54.6 (maj), 32.3, 26.3 (min), 25.9 (maj), 21.1 (maj), 20.8, 20.3 (min) ppm. open in new tab
26. HRMS (ESI+): m/z calcd for C 23 H 28 N 2 O 2 Na [M + Na] + 387.2048, found. 387.2061. 2-(tert-Butyl)-N-(3-fluorophenyl)-4-oxo-1-(1- phenylethyl)azetidine-3-carboxamide (7hea) and (8hea) Purification by flash chromatography (EtOAc : Hex 1 : 4-1 : 3, SiO 2 ) gave one fraction, a mixture of two diastereoisomers (253 mg, 0.69 mmol, 69%, ratio 65 : 35, yellow oil). Overall de = 30%. open in new tab
27. H NMR (400 MHz, CDCl 3 ) d: 8.88 (s, 0.65 H, NH), 8.57 (s, 0.35
28. H, NH), 7.55-7.51 (m, 1 H, ArH), 7.44-7.30 (m, 5 H, ArH), 7.26- 7.10 (m, 2 H, ArH), 6.84-6.75 (m, 1 H, ArH), 4.62 (q, 0.35 H, J = 7.2 Hz, CHCH 3 ), 4.52 (q, 0.65 H, J = 7.2 Hz, CHCH 3 ), 3.92 (d, 0.65 H, J = 2.8 Hz, H-3), 3.77 (d, 0.65 H, J = 2.8 Hz, H-4), 3.74 (d, 0.35 H, J = 2.8 Hz, H-3), 3.70 (d, 0.35 H, J = 2.8 Hz, H-4), 1.86 (d, 1.05 H, J = 7.2 Hz, CH 3 ), 1.79 (d, 1.95 H, J = 7.2 Hz, CH 3 ), 0.98 (s, 3.15 H, t Bu), 0.90 (s, 5.85 H, t Bu) ppm. 13 C NMR (100 MHz, CDCl 3 ) d: 166.3 (min), 166.2 (maj), 164.0, 162.9 (d, 1 J CF = 243 Hz) (min), 162.8 (d, 1 J CF = 240 Hz) (maj), 141.3 (maj), 140.9 (min), 139.1 (d, 3 J CF = 11 Hz) (maj), 139.0 (d, 3 J CF = 11 Hz) (min), 130.0 (d, 3 J CF = 9 Hz) (min), 129.9 (d, 3 J CF = 9 Hz) (maj), 128.9 (min), 128.7 (maj), 127.8 (min), 127.5 (maj), 127.0 (maj), 126.6 (min), 115.0 (d, 4 J CF = 3 Hz) (min), 114.9 (d, 4 J CF = 3 Hz) (maj), 111.1 (d, 2 J CF = 21 Hz) (min), 111.0 (d, 2 J CF = 21 Hz) (maj), 107.3 (d, 2 J CF = 26 Hz) (min), 107.2 (d, 2 J CF = 26 Hz) (maj), 66.2 (maj), 64.0 (min), 57.2 (maj), 56.5 (min), 55.0 (maj), 54.9 (min), 32.3, 26.3 (min), 25.9 (maj), 21.1 (maj), 20.3 (min) ppm. HRMS (ESI+): m/z calcd for C 22 H 25 FN 2 O 2 Na [M + Na] + 391.1798, found. 391.1786. 2-(tert-Butyl)-N-(4-fluorophenyl)-4-oxo-1-(1- phenylethyl)azetidine-3-carboxamide (7iea) and (8iea) Purification by flash chromatography (EtOAc : Hex 1 : 4-1 : 3, SiO 2 ) gave one fraction, a mixture of two diastereoisomers (283 mg, 0.77 mmol, 77%, ratio 68 : 32, yellow oil). Overall de = 36%. 1 H NMR (400 MHz, CDCl 3 ) d: 8.70 (s, 0.68 H, NH), 8.44 (s, 0.32 H, NH), 7.53-7.49 (m, 2 H, ArH), 7.44-7.30 (m, 5 H, ArH), 7.04-6.95 (m, 2 H, ArH), 4.61 (q, 0.32 H, J = 7.2 Hz, CHCH 3 ), 4.52 (q, 0.68 H, J = 7.2 Hz, CHCH 3 ), 3.90 (d, 0.68 H, J = 2.8 Hz, H-3), 3.75 (d, 0.68 H, J = 2.8 Hz, H-4), 3.72 (d, 0.32 H, J = 2.8 Hz, H-3), 3.68 (d, 0.32 H, J = 2.8 Hz, H-4), 1.87 (d, 0.96 H, J = 7.2 Hz, CH 3 ), 1.78 (d, 2.04 H, J = 7.2 Hz, CH 3 ), 0.97 (s, 2.88 H, t Bu), 0.89 (s, 6.12 H, t Bu) ppm. 13 C NMR (100 MHz, CDCl 3 ) d: 166.4 (min), 166.3 (maj), 164.0 (maj), 163.9 (min), 159.4 (d, 1 J CF = 242 Hz) (min), 159.3 (d, 1 J CF = 242 Hz) (maj), 141.3 (maj), 140.9 (min), 133.6 (d, 4 J CF = 3 Hz) (maj), 133.5 (d, 4 J CF = 3 Hz) (min), 128.9 (min), 128.7 (maj), 127.8 (min), 127.5 (maj), 127.0 (maj), 126.6 (min), 121.6 (d, 3 J CF = 8 Hz) (min), 121.4 (d, 3 J CF = 8 open in new tab
29. Hz) (maj), 115.5 (d, 2 J CF = 22 Hz) (min), 115.4 (d, 2 J CF = 22 Hz) (maj), 66.3 (maj), 64.1 (min), 57.2 (maj), 56.5 (min), 54.8 (min), 54.7 (maj), 32.3, 26.3 (min), 25.9 (maj), 21.1 (maj), 20.3 (min) ppm. HRMS (ESI+): m/z calcd for C 22 H 25 FN 2 O 2 Na [M + Na] + 391.1798, found. 391.1789. open in new tab
30. N-(3-Fluorophenyl)-2-(2-methylpent-4-en-2-yl)-4-oxo-1-(1- phenylethyl)azetidine-3-carboxamide (7hfa) and (8hfa) Purification by flash chromatography (EtOAc : Hex 1 : 4-1 : 3, SiO 2 ) gave one fraction, a mixture of two diastereoisomers (153 mg, 0.39 mmol, 39%, ratio 65 : 35, yellow oil). Overall de = 30%. 1 H NMR (400 MHz, CDCl 3 ) d: 8.76 (s, 0.65 H, NH), 8.53 (s, 0.35 H, NH), 7.55-7.51 (m, 1 H, ArH), 7.45-7.43 (m, 1 H, ArH), 7.40-7.34 (m, 2 H, ArH), 7.33-7.29 (m, 2 H, ArH), 7.25- 7.12 (m, 2 H, ArH), 6.84-6.76 (m, 1 H, ArH), 5.81-5.70 (m, 1 H, CH 2 CHQCH 2 ), 5.09-5.05 (m, 1 H, CH 2 CHQCH 2 ), 5.00-4.94 (m, 1 H, CH 2 CHQCH 2 ), 4.64 (q, 0.35 H, J = 7.2 Hz, CHCH 3 ), 4.51 (q, 0.65 H, J = 7.2 Hz, CHCH 3 ), 3.99 (d, 0.65 H, J = 2.8 Hz, H-3), 3.82-3.80 (m, 1 H, H-3, H-4), 3.78 (d, 0.35 H, J = 2.8 Hz, H-4), 2.05-1.91 (m, 2 H, CH 2 CHQCH 2 ), 1.87 (d, 1.05 H, J = 7.2 Hz, CH 3 ), 1.79 (d, 1.95 H, J = 7.2 Hz, CH 3 ), 0.94 (s, 2.1 H, C(CH 3 ) 2 ), 0.86 (s, 1.95 H, C(CH 3 ) 2 ), 0.85 (s, 1.95 H, C(CH 3 ) 2 ) ppm. 13 C NMR (100 MHz, CDCl 3 ) d: 166.2 (min), 166.1 (maj), 164.1 (maj), 163.9 (min), 162.9 (d, 1 J CF = 243 Hz) (min), 162.8 (d, 1 J CF = 243 Hz) (maj), 141.3 (maj), 140.9 (min), 139.0 (d, 3 J CF = 10 Hz) (maj), 138.9 (d, 3 J CF = 10 Hz) (min), 133.4 (maj), 133.3 (min), 130.0 (d, 3 J CF = 10 Hz) (min), 129.9 (d, 3 J CF = 10 Hz) (maj), 128.9 (min), 128.7 (maj), 127.8 (min), 127.6 (maj), 127.0 (maj), 126.6 (min), 118.5 (min), 118.4 (maj), 115.0 (d, 4 J CF = 3 Hz) (min), 114.9 (d, 4 J CF = 3 Hz) (maj), 111.1 (d, 2 J CF = open in new tab
31. Hz) (min), 111.0 (d, 2 J CF = 21 Hz) (maj), 107.3 (d, 2 J CF = 26 Hz) (min), 107.2 (d, 2 J CF = 26 Hz) (maj), 65.4 (maj), 63.4 (min), 57.5 (maj), 56.6 (min), 54.8 (min), 54.7 (maj), 43.6 (min), 43.4 (maj), 35.3 (maj), 35.2 (min), 23.6 (min), 23.2 (maj), 22.9 (min), 22.4 (maj), 21.3 (maj), 20.4 (min), ppm. HRMS (ESI+): m/z calcd for C 24 H 27 FN 2 O 2 Na [M + Na] + 417.1954, found. 417.1951. open in new tab
32. N-(4-Fluorophenyl)-2-(2-methylpent-4-en-2-yl)-4-oxo-1-(1- phenylethyl)azetidine-3-carboxamide (7ifa) and (8ifa) Purification by flash chromatography (EtOAc : Hex 1 : 4-1 : 3, SiO 2 ) gave one fraction, a mixture of two diastereoisomers (193 mg, 0.49 mmol, 49%, ratio 64 : 36, yellow oil). Overall de = 28%. 1 H NMR (400 MHz, CDCl 3 ) d: 8.59 (s, 0.64 H, NH), 8.40 (s, 0.36 H, NH), 7.54-7.50 (m, 2 H, ArH), 7.45-7.42 (m, 1 H, ArH), 7.40-7.34 (m, 2 H, ArH), 7.32-7.29 (m, 2 H, ArH), 7.05- 6.97 (m, 2 H, ArH), 5.81-5.70 (m, 1 H, CH 2 CHQCH 2 ), 5.08-5.05 (m, 1 H, CH 2 CHQCH 2 ), 5.00-4.94 (m, 1 H, CH 2 CHQCH 2 ), 4.64 (q, 0.36 H, J = 7.2 Hz, CHCH 3 ), 4.51 (q, 0.64 H, J = 7.2 Hz, CHCH 3 ), 3.97 (d, 0.64 H, J = 2.4 Hz, H-3), 3.80-3.79 (m, 1 H, H-3, H-4), 3.77 (d, 0.36 H, J = 2.4 Hz, H-4), 2.09-1.91 (m, 2 H, CH 2 CHQCH 2 ), 1.87 (d, 1.08 H, J = 7.2 Hz, CH 3 ), 1.79 (d, 1.92 H, J = 7.2 Hz, CH 3 ), 0.95 (s, 1.08 H, C(CH 3 ) 2 ), 0.94 (s, 1.08 H, C(CH 3 ) 2 ), 0.86 (s, 1.92 H, C(CH 3 ) 2 ), 0.85 (s, 1.92 H, C(CH 3 ) 2 ) ppm. 13 C NMR (100 MHz, CDCl 3 ) d: 166.4 (min), 166.2 (maj), 163.9 (maj), 163.8 (min), 159.4 (d, 1 J CF = 242 Hz) (min), 159.3 (d, 1 J CF = 242 Hz) (maj), 141.4 (maj), 140.9 (min), 133.6 (d, 4 J CF = 3 Hz), 133.5 (maj), 133.4 (min), 128.9 (min), 128.7 (maj), 127.8 (min), 127.6 (maj), 127.0 (maj), 126.6 (min), 121.6 (d, 2 J CF = open in new tab
33. Hz) (min), 121.5 (d, 3 J CF = 8 Hz) (maj), 118.5 (min), 118.4 (maj), 115.6 (d, 2 J CF = 22 Hz) (min), 115.5 (d, 2 J CF = 22 Hz) (maj), 65.6 (maj), 63.5 (min), 57.5 (maj), 56.6 (min), 54.7 (min), 54.5 (maj), 43.7 (min), 43.5 (maj), 35.3, 23.6 (min), 23.2 (maj), 22.9 (min), 22.5 (maj), 21.3 (maj), 20.4 (min), ppm. HRMS (ESI+): m/z calcd for C 24 H 27 FN 2 O 2 Na [M + Na] + 417.1954, found. 417.1940. 1-Isopropyl-2-oxo-N-phenyl-4-(2-phenylpent-4-en-2-yl)azetidine- 3-carboxamide (7ahd) and (8ahd) Purification by flash chromatography (EtOAc : Hex 1 : 4, SiO 2 ) gave one fraction, a mixture of two diastereoisomers (188 mg, 0.5 mmol, 50%, ratio 50 : 50, yellow oil). 1 H NMR (400 MHz, CDCl 3 ) d: 8.50 (s, 0.5 H, NH), 7.95 (s, 0.5 H, NH), 7.57-7.54 (m, 1 H, ArH), 7.46-7.21(m, 8 H, ArH), 7.12-7.03 (m, 1 H, ArH), 5.67-5.56 (m, 0.5 H, CH 2 CHQCH 2 ), 5.42-5.31 (m, 0.5 H, CH 2 CHQCH 2 ), 5.14-4.93 (m, 2 H, CH 2 CHQCH 2 ), 4.41 (d, 0.5 H, J = 2.0 Hz, H-3), 4.30 (d, 0.5 H, J = 2.0 Hz, H-3), 3.84 (d, 0.5 H, J = 2.0 Hz, H-4), 3.54 (d, 0.5 H, J = 2.0 Hz, H-4), 3.44 (sep, 0.5 H, J = 6.8 Hz, CH(CH 3 ) 2 ), 2.91 (dd, 0.5 H, 2 J = 14.0 Hz, open in new tab
34. J = 5.6 Hz, CH 2 CHQCH 2 ), 2.83 (dd, 0.5 H, 2 J = 14.0 Hz, 3 J = 5.6 Hz, CH 2 CHQCH 2 ), 2.70 (sep, 0.5 H, J = 6.4 Hz, CH(CH 3 ) 2 ), 2.44 (dd, 0.5 H, 2 J = 14.0 Hz, 3 J = 8.4 Hz, CH 2 CHQCH 2 ), 2.33 (dd, 0.5 H, 2 J = 14.0 Hz, 3 J = 8.4 Hz, CH 2 CHQCH 2 ), 1.46 (d, 1.5 H, J = 6.8 Hz, CH(CH 3 ) 2 ), 1.44 (s, 1.5 H, CH 3 ), 1.40 (s, 1.5 H, CH 3 ), 1.25 (d, 1.5 H, J = 6.8 Hz, CH(CH 3 ) 2 ), 1.19 (d, 1.5 H, J = 6.4 Hz, CH(CH 3 ) 2 ), 0.91 (d, 1.5 H, J = 6.4 Hz, CH(CH 3 ) 2 ), ppm. 13 C NMR (100 MHz, CDCl 3 ) d: 169.3, 166.2, 164.0, 163.5, 141.3, 141.0, 137.5, 129.1, 129.0, 128.9, 128.9, 128.8, 128.7, 127.8, 127.5, 127.0, 126.6, 124.5, 124.4, 120.0, 119.9, 119.8, 119.7, 83.1, 66.5, 64.1, 62.2, 57.1, 56.5, 54.8, 54.6, 42.4, 32.3, 28.0, 27.5, 27.4, 26.3, 25.9, 21.1, 20.3, ppm. Notes and references 1 (a) http://apps.who.int/iris/bitstream/10665/148114/1/97892 41564854_eng.pdf?ua=1; (b) http://ec.europa.eu/eurostat/ statistics-explained/index.php/File:Causes_of_death_%E2% 80%94_standardised_death_rate,_2012_%28per_100_000_ inhabitants%29_YB15.png. open in new tab
35. J. L. Betters and L. Yu, Clin. Pharm. Ther., 2010, 87, 117-121. open in new tab
36. E. K. Gupta and M. K. Ito, Heart Dis., 2002, 4, 399-409; open in new tab
37. J. W. Clader, J. Med. Chem., 2004, 47, 1-9. open in new tab
38. S. B. Rosenblum, T. Huynh, A. Afonso, H. R. Davis, N. Yumibe, J. W. Clader and D. A. Burnett, J. Med. Chem., 1998, 41, 973-980. open in new tab
39. S. Karlsson and J. H. Sorensen, Org. Process Res. Dev., 2012, 16, 586-594. open in new tab
40. W. Kramer, D. Corsiero, F. Girbig and G. Jähne, Biochim. Biophys. Acta, 2006, 1, 45-54. open in new tab
41. B. G. Salisbury, H. R. Davis, R. E. Burrier, D. A. Burnett, G. Boykow, M. A. Caplen, A. L. Clemmons, D. S. Compton, L. M Hoos, D. G. McGregor, R. Schnitzer-Polokoff, A. A. Smith, B. C. Weig, D. L. Zilli, J. W. Clader and E. J. Sybertza, Atherosclerosis, 1995, 115, 45-63. open in new tab
42. Y. Yamamoto, Y. Watanabe and S. Ohnishi, Chem. Pharm. Bull., 1987, 35, 1860-1870; (b) Y. Yamamoto and Y. Watanabe, Chem. Pharm. Bull., 1987, 35, 1871-1879; open in new tab
43. F. Xu, J. D. Armstrong, G. X. Zhou, B. Simmons, D. Hughes, Z. Ge and E. J. J. Grabowski, J. Am. Chem. Soc., 2004, 126, 13002-13009. open in new tab
44. K. Janikowska, P. Pawelska and S. Makowiec, Synthesis, 2011, 69-72.
45. S. Dugar, J. W. Clader, T. Chan and H. Davis, J. Med. Chem., 1995, 38, 4875-4877. open in new tab
46. A. Zakaszewska and E. Najda nad S. Makowiec, New J. Chem., 2016, 40, 6546-6549. open in new tab
47. K. Janikowska, S. Makowiec and J. Rachoń, Helv. Chim. Acta, 2012, 95, 461-468. open in new tab
48. S. P. Raillard, W. Chen, E. Sullivan, W. Bajjalieh, A. Bhandari and T. A. Baer, J. Comb. Chem., 2002, 4, 470-474; (b) E. J. Murray, R. C. Crowley, A. Truman, S. R. Clarke, J. A. Cottam, G. P. Jadhav, V. R. Steele, P. O'Shea, C. Lindholm, A. Cockayne, S. R. Chhabra, W. C. Chan and P. Williams, J. Med. Chem., 2014, 57, 2813-2819;
49. P. Jouin, B. Castro and D. Nisato, J. Chem. Soc., Perkin Trans. 1, 1987, 1177-1182. open in new tab
50. C. Palomo, J. M. Aizpurua, I. Ganboa and M. Oiarbide, Eur. J. Org. Chem., 1999, 3223-3235; (b) C. R. Pitts and T. Lectka, Chem. Rev., 2014, 114, 7930-7953; (c) R. Fernandez, A. Ferrete, J. M. Lassaletta, J. M. Llera and A. Monge, Angew. Chem., 2000, 112, 3015-3019; (d) G. I. Georg and Z. Wu, Tetrahedron Lett., 1994, 35, 381-384; (e) J. Aszodi, A. Bonnet and G. Teutsch, Tetrahedron, 1990, 46, 1579-1586. 15 (a) N. N. Romanova, V. A. Budylin, G. G. Grishina, V. M. Potapov, M. L. Demchuk, I. Yu. Sivkova and Yu. G. Bundel, Khim. Geterotsikl. Soedin., 1986, 5, 607-611; (b) S. G. Daviesa, C. J. R. Hedgecockb and J. M. McKennaa, Tetrahedron: Asymmetry, 1995, 6, 827-830; (c) S. D. Bull, S. G. Davies, P. M. Kelly, M. Gianotti and A. D. Smith, J. Chem. Soc., Perkin Trans. 1, 2001, 3106-3111; (d) C. D. Evans, M. F. Mahon, P. C. Andrews, J. Muir and S. D. Bull, Org. Lett., 2011, 13, 6276-6279; (e) C. Lucatelli, F. Viton, Y. Gimbert and A. E. Greene, J. Org. Chem., 2002, 67, 9468-9470. open in new tab
51. S. Makowiec, E. Najda and K. Janikowska, J. Heterocycl. Chem., 2015, 52, 205-210. open in new tab
52. J. E. Lynch, S. M. Riseman, W. L. Laswell, D. M. Tschaen, R. P. Volante, G. B. Smith and I. Shinkaipub, J. Org. Chem., 1989, 54, 3792-3796; (b) H. R. Seikaly and T. T. Tilwell, Tetrahedron, 1986, 42, 2587-2613; (c) D. A. Nelson, J. Org. Chem., 1972, 37, 1447-1449. open in new tab
53. F. P. Cossio, A. Arrieta, B. Lecea and J. M. Ugalde, J. Am. Chem. Soc., 1994, 116, 2085-2093; (b) C. Palomo, F. P. Cossio, C. Cuevas, B. Lecea, A. Mielgo, P. Roman, A. Luque and M. Martinez-Ripoll, J. Am. Chem. Soc., 1992, 114, 9360-9369.
54. W. Van Brabandt, M. Vanwalleghem, M. D'hooghe and N. De Kimpe, J. Org. Chem., 2006, 71, 7083-7086; (b) D. R. Wagle, C. Garai, J. Chiang, M. G. Monteleone, B. E. Kurys, T. W. Strohmeyer, V. R. Hegde, M. S. Manhas and A. K. Bose, J. Org. Chem., 1988, 53, 4227-4236; (c) D. R. Wagle, C. Garai, M. G. Monteleone and A. K. Bose, Tetrahedron Lett., 1988, 29, 1649-1652; (d) A. D. Brown and E. W. Colvin, Tetrahedron Lett., 1991, 32, 5187-5190.
55. A. Trifonova and P. G. Andersson, Tetrahedron: Asymmetry, 2004, 15, 445-452. open in new tab
56. C. Spino, C. Godbout, Ch. Beaulieu, M. Harter, T. M. Mwene-Mbeja and L. Boisvert, J. Am. Chem. Soc., 2004, 126, 13312-13319. open in new tab
57. P. Punda and S. Makowiec, Synth. Commun., 2013, 43, 1362-1367. open in new tab
58. M. Yoshida, E. Masaki, T. Terumine and S. Hara, Synthesis, 2014, 1367-1373; (b) M. Yoshida, T. Terumine, E. Masaki and S. Hara, J. Org. Chem., 2013, 78, 10853-10859; open in new tab
59. K. Hiroi, J. Abe, K. Suya, S. Sato and T. Koyama, J. Org. Chem., 1994, 59, 203-213. open in new tab
60. N. Pawelska, Ł. Ponikiewski and S. Makowiec, J. Fluorine Chem., 2012, 144, 65-68. open in new tab
61. P. Punda, Ł. Ponikiewski and S. Makowiec, Helv. Chim. Acta, 2013, 96, 2081-2091. open in new tab
62. H. K. Lee, J. P. Lee, G. H. Lee and Ch. S. Pak, Synlett, 1996, 1209-1210. open in new tab
63. N. Boyer, P. Gloanec, G. Nanteuil, P. Jubaulta and J. Ch. Quiriona, Tetrahedron, 2007, 63, 12352-12366. open in new tab

show (63) hide

Verified by:

Gdańsk University of Technology